Skip to main content

Conference Features

Bipolar Disorders
June 04, 2019
SAN FRANCISCO—The antipsychotic cariprazine was effective in improving depressive symptoms in patients with bipolar depression and concurrent manic symptoms, according to a poster presented at the American Psychiatric Association’s annual meeting.
APA Annual Meeting
June 04, 2019
SAN FRANCISCO—Treatment with a novel combination of 2 common medications was associated with “a rapid and significant reduction in symptoms of depression,” compared with treatment with one of the components, according to a poster presented at the American Psychiatric Association’s Annual Meeting.
APA MEETING
May 21, 2019
SAN FRANCISCO—Tardive dyskinesia (TD) is strongly linked with older age, medical comorbidity, and hospitalizations, according to a study of US veterans with serious mental illness presented during a poster session at the American Psychiatric Association’s annual meeting.
APA MEETING
May 21, 2019
SAN FRANCISCO—Combining the cognitive enhancer memantine with the antidepressant escitalopram was more effective than escitalopram alone in easing depression and apathy in older adults with depression, according to a study presented during a poster session at the American Psychiatric Association’s annual meeting.
APA MEETING
May 21, 2019
SAN FRANCISCO—People directly exposed as children to the Sept. 11, 2001 attacks in New York City have higher rates of psychiatric and physical disorders, compared with people not directly exposed to the mass trauma event in childhood, according to a study presented at the American Psychiatric Association’s annual meeting.

More from the meeting

APA MEETING
May 21, 2019
SAN FRANCISCO—A once-daily asenapine patch is effective for the treatment of schizophrenia in adults, researchers reported during a poster session at the American Psychiatric Association’s annual meeting.
APA MEETING
May 21, 2019
SAN FRANCISCO—Cognitive behavioral therapy (CBT), commonly recommended as part of a treatment plan for mood disorders, can also be an effective intervention for psychotic disorders, a presenter at the American Psychiatric Association’s annual meeting argued.
APA MEETING
May 20, 2019
SAN FRANCISCO—Adding samidorphan to olanzapine did not diminish the antipsychotic efficacy of olanzapine alone in adults with schizophrenia, according to data presented during a poster session at the American Psychiatric Association’s annual meeting.
APA MEETING
May 19, 2019
SAN FRANCISCO—Panels of speakers at 2 American Psychiatric Association (APA) Annual Meeting sessions encouraged clinicians to consider prescribing clozapine in patients with treatment-refractory schizophrenia, despite the many challenges which come with using the drug.
APA MEETING
May 18, 2019
SAN FRANCISCO—Patient age is significantly associated with the type of extrapyramidal symptoms that stem from antipsychotic use, according to a study presented during a poster session at the American Psychiatric Association’s annual meeting.
Back to Top